116 related articles for article (PubMed ID: 36604703)
1. The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.
Lawson McLean AC; Freier A; Lawson McLean A; Kruse J; Rosahl S
Orphanet J Rare Dis; 2023 Jan; 18(1):3. PubMed ID: 36604703
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.
Ferner RE; Shaw A; Evans DG; McAleer D; Halliday D; Parry A; Raymond FL; Durie-Gair J; Hanemann CO; Hornigold R; Axon P; Golding JF
J Neurol; 2014 May; 261(5):963-9. PubMed ID: 24619350
[TBL] [Abstract][Full Text] [Related]
3. The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2.
Hornigold RE; Golding JF; Leschziner G; Obholzer R; Gleeson MJ; Thomas N; Walsh D; Saeed S; Ferner RE
J Neurol Surg B Skull Base; 2012 Apr; 73(2):104-11. PubMed ID: 23543835
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.
Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF
Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237
[TBL] [Abstract][Full Text] [Related]
5. The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis.
Freier A; Lawson McLean AC; Loeschner D; Rosahl SK; Kruse J
Sci Rep; 2024 Mar; 14(1):6934. PubMed ID: 38521834
[TBL] [Abstract][Full Text] [Related]
6. Association between patient-reported outcomes and objective disease indices in people with NF2.
Shukla A; Hsu FC; Slobogean B; Langmead S; Lu Y; Blakeley JO; Strowd RE
Neurol Clin Pract; 2019 Aug; 9(4):322-329. PubMed ID: 31583187
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.
Hamoy-Jimenez G; Kim R; Suppiah S; Zadeh G; Bril V; Barnett C
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i141-i149. PubMed ID: 32642740
[TBL] [Abstract][Full Text] [Related]
8. Quality of life after pulmonary embolism: Prospective validation of the German version of the PEmb-QoL questionnaire.
Frey PM; Méan M; Limacher A; Leiss W; Schwab N; Rochat M; Aujesky D
Thromb Res; 2015 Jun; 135(6):1087-92. PubMed ID: 25887632
[TBL] [Abstract][Full Text] [Related]
9. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
10. Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member.
Elsner SA; Salek SS; Finlay AY; Hagemeier A; Bottomley CJ; Katalinic A; Waldmann A
Health Qual Life Outcomes; 2021 Mar; 19(1):106. PubMed ID: 33761949
[TBL] [Abstract][Full Text] [Related]
11. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
[TBL] [Abstract][Full Text] [Related]
12. Validation and Psychometric Properties of the German Version of the SWAL-QOL.
Kraus EM; Rommel N; Stoll LH; Oettinger A; Vogel AP; Synofzik M
Dysphagia; 2018 Aug; 33(4):431-440. PubMed ID: 29313143
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life (QoL) Assessment in Patients with Neurofibromatosis Type 2 (NF2).
Cosetti MK; Golfinos JG; Roland JT
Otolaryngol Head Neck Surg; 2015 Oct; 153(4):599-605. PubMed ID: 25779467
[TBL] [Abstract][Full Text] [Related]
14. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Spanish-language version of the Prolapse Quality of Life questionnaire in Chilean women.
Flores-Espinoza C; Araya AX; Pizarro-Berdichevsky J; Santos V; Ferrer M; Garin O; Swift S; Digesu AG
Int Urogynecol J; 2015 Jan; 26(1):123-30. PubMed ID: 25224147
[TBL] [Abstract][Full Text] [Related]
16. First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.
Funes CJ; Mace RA; Macklin EA; Plotkin SR; Jordan JT; Vranceanu AM
J Neurooncol; 2019 Jul; 143(3):505-513. PubMed ID: 31049826
[TBL] [Abstract][Full Text] [Related]
17. Cultural adaptation and validation of the Systemic Sclerosis Quality of Life questionnaire into Arabic language.
Alian SM; Sherby NA; Sarhan SA
Clin Rheumatol; 2021 Apr; 40(4):1409-1416. PubMed ID: 32918142
[TBL] [Abstract][Full Text] [Related]
18. Translation and validation of restless leg syndrome quality of life questionnaire in Hindi language.
Vishwakarma K; Lahan V; Gupta R; Goel D; Dhasmana DC; Sharma T; Kalra J
Neurol India; 2012; 60(5):476-80. PubMed ID: 23135023
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Malay version of the p-QOL questionnaire.
Dasrilsyah RA; Ng BK; Atan IK; Khong SY; Nusee Z; Lim PS
Int Urogynecol J; 2021 Dec; 32(12):3163-3167. PubMed ID: 32506230
[TBL] [Abstract][Full Text] [Related]
20. The validity and reliability of the Turkish version of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer.
Senkal HA; Hayran M; Karakaya E; Yueh B; Weymuller EA; Hoşal AŞ
Am J Otolaryngol; 2012; 33(4):417-26. PubMed ID: 22137146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
